Aug 22, 2019

COMPANY NEWS; DSM TO ACQUIRE CATALYTICA FOR $800 MILLION By Bloomberg News August 4, 2000, Section C, Page 3 Buy Reprints TimesMachine is an exclusive benefit for home delivery and digital subscribers. DSM N.V. of the Netherlands agreed yesterday to buy Catalytica Inc. for about $800 million in cash and debt to strengthen its position as the world's biggest supplier of high-profit pharmaceutical ingredients. DSM plans to keep Catalytica's drug division and spin off the combustion systems and advanced technologies units. Investors in Catalytica, based in Mountain View, Calif., will gain stock in the new business and be paid $9 to $10 a share, depending on taxes associated with the spinoff. DSM will pay about $750 million in cash and assume about $50 million in debt. Advertisement